Chlamydia pneumoniae and osteoporosis-associated bone loss: A new risk factor?

Osteoporosis International

Volumn 24, Issue 5, 2013, Pages 1677-1682

  Di Pietro, M ^a   Schiavoni, G ^a   Sessa, V ^b   Pallotta, F ^c   Costanzo, G ^d   Sessa, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

C. pneumoniae; IL 1; IL 6; Osteoporosis; sRANKL OPG; TNF

Indexed keywords

BACTERIAL DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE TISSUE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; FEMALE; FEMUR HEAD; FEMUR NECK FRACTURE; HIP ARTHROPLASTY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; OSTEOLYSIS; OSTEOPOROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; DNA, BACTERIAL; FEMALE; FEMORAL NECK FRACTURES; FEMUR HEAD; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; OSTEOARTHRITIS, HIP; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; RISK FACTORS;

EID: 84880739340     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-2217-1     Document Type: Article

References (24)

1. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276-1287
2. Brewer L, Williams D, Moore A (2011) Current and future treatment options in osteoporosis. Eur J Clin Pharmacol 67:321-331
3. Claro T, Widaa A, O'Seaghdha M, Miajlovic H, Foster TJ, O'Brien FJ, Kerrigan SW (2011) Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One 6:e18748
4. Schreiner H, Markowitz K, Miryalkar M, Moore D, Diehl S, Fine DH (2011) Aggregatibacter actinomycetemcomitans-induced bone loss and antibody response in three rat strains. J Periodontol 82:142-150
5. Delpino MV, Fossati CA, Baldi PC (2009) Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect Immun 77:984-995
6. Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79:1585-1591
7. Marriott I (2004) Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression. Immunol Res 30:291-308
8. Bailey L, Engström P, Nordström A, Bergström S, Waldenström A, Nordström P (2008) Chlamydia pneumoniae infection results in generalized bone loss in mice. Microbes Infect 10:1175-1181
9. Rizzo A, Di Domenico M, Carratelli CR, Mazzola N, Paolillo R (2011) Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae. Cytokine 56:450-457
10. Di Pietro M, Tramonti A, De Santis F, De Biase D, Schiavoni G, Sessa R (2012) Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae. J Biological Regulators & Homeostatic Agents 26:277-284
11. Bellmann-Weiler R, Martinz V, Kurz K, Engl S, Feistritzer C, Fuchs D, Rupp J, Paldanius M, Weiss G (2010) Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma. Immunobiology 215:842-848
12. Rosenfeld ME, Campbell LA (2011) Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106:858-867
13. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, Del Piano M, Cipriani P (2009) Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 22:9-14
14. Gracey E, Inman RD (2011) Chlamydia-induced ReA: immune imbalances and persistent pathogens. Nat Rev Rheumatol 8:55-59
15. Villareal C, Whittum-Hudson JA, Hudson AP (2002) Persistent Chlamydiae and chronic arthritis. Arthritis Res 4:5-9
16. Netea MG, Selzmann CH, Kullberg BJ (2000) Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 30:541-549
17. Takano R, Yamaguchi H, Sugimoto S, Nakamura S, Friedman H, Yamamoto Y (2005) Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae. Curr Microbiol 50:160-166
18. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL (1999) Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 154:203-210
19. WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group World Health Organ Tech Rep Ser 843:1-129
20. Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, Nicoletti M, Santino I, del Piano M (2007) Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 195:e224-e230
21. Gieffers J, van Zandbergen G, Rupp J, Sayk F, Krüger S, Ehlers S, Solbach W, Maass M (2004) Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J 23:506-510
22. Gérard HC, Schumacher HR, El-Gabalawy H, Goldbach-Mansky R, Hudson AP (2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 29:17-24
23. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP (2009) Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 60:1311-1316
24. Teti A (2011) Bone development: overview of bone cells and signaling. Curr Osteoporos Rep 9:264-273